144 Chapter 8 RESULTS A total of 240 participants were potentially eligible for the study. We excluded 29 (12%) participants because they did not meet the criteria for the clinical diagnosis of AT and 11 (5%) participants were excluded as they did not provide informed consent. 200 participants fully completed the baseline questionnaire and were included in the study. For the primary outcome measure 148 (74%), 139 (70%) and 116 (58%) participants completed the questionnaire at 6, 12 and 24 weeks respectively. In Q1 and Q5 respectively 64% and 67% of the participants completed the questionnaire at 24-weeks. The included participants had a median age of 51 years, were mainly male (60.5%), had a median symptom duration of 94 weeks and were active in sports before their injury in the majority of the cases (91%). The collected participants’ characteristics are depicted in Table 1 for the overall population. Adjunct conservative therapies were performed during follow-up in 33 participants (17%), including Extracorporeal Shockwave Therapy (ESWT) (7%), orthotic devices (5%) and prolotherapy (2%). 10 patients with high SES (Q1) received adjunct therapies compared to 6 patients with low SES (Q5). This difference was not statistically significant (p=0.497).
RkJQdWJsaXNoZXIy MTk4NDMw